Lilly Is Selling Zepbound Vials at 50% Discount to Shots
Bloomberg Businessweek
Intro
This chapter explores Eli Lilly's novel approach to distributing its weight loss drug ZEPBOWN, allowing patients to self-fill vials at a monthly cost of $399. It discusses the potential benefits and challenges of this self-administration method in response to supply shortages and patient preferences.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
